Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study

•Local stage of advanced cervical cancer changes in 27% comparing MRI and clinical examination.•For treatment allocation important clinical stages IB1-IIA2 changed to IIB on MRI in 31%.•Pelvic wall/bladder infiltration vary considerably, likely due to different definitions for clinical and imaging findings.•50% of this cohort are allocated to stage IIIC with FIGO 2018, obscuring local tumour extent.•TNM offers the most differentiated stage allocation with 26 subgroups in this cohort.